Brett Reynolds Appointed As Senior VP And CFO Of Uroplasty, Inc. (UPI)

Aug. 13, 2013 1:57 PM ETUPI
MissionIR profile picture
MissionIR's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Small cap

Contributor Since 2010

We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to building shareholder value. View our website at MissionIR provides investor relations services to publicly traded companies in exchange for compensation. The content we provide via Seeking Alpha may be part of our efforts to widen a client’s exposure. To read our full disclaimer, visit

Yesterday, medical device company Uroplasty announced that Brett A. Reynolds has been appointed as Senior Vice President and Chief Financial Officer.

Mr. Reynolds' experience spans over 20 years in finance and operations. He spent 10 years with Synovis Life Technologies, a Twin Cities-based medical device manufacturer acquired by Baxter International last year. While with Synovis, he held various senior positions, including CFO.

Prior to Synovis, Mr. Reynolds served in executive financial positions at Chiquita Processed Foods, Arthur Andersen, and Deloitte & Touche. Mr. Reynolds is a Certified Public Accountant and holds a BA in Accounting and an MBA from the University of Minnesota's Carlson School of Management.

Rob Kill, Uroplasty's President and CEO, remarked, "Brett's significant industry operational experience and proven public company financial leadership will be a valuable asset to Uroplasty. His track record of building strong financial organizations and processes expands the depth of our executive leadership team and we are delighted to have him on board in this key role."

For more information, visit

Please see disclaimer on the MissionIR website

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.